Patent · US Active

Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof

US8377977B2 · kind B2 · utility

0Cited by

45References

6Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thomas Friedl · Seekirchen am Wallersee, AT
Wolfram EISENREICH · Ulm, DE

Key dates

Filing date	Jul 22, 2009
Grant date	Feb 19, 2013
Priority date	—
Expiry date	May 9, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2866
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.